Acidaminococcaceae: The Amino Acid Fermenters Bridging Metabolism and Gut Health

The family Acidaminococcaceae represents a unique and functionally specialized group within the human gut microbiome, distinguished by their unusual Gram-negative cell wall structure despite belonging to the phylum Bacillota (formerly Firmicutes). As master fermenters of amino acids, members of this family occupy a distinct metabolic niche, thriving on protein-derived substrates rather than the carbohydrates that fuel most gut bacteria. This specialization positions them as key players in the metabolism of dietary protein and in the cross-feeding networks that sustain the broader microbial community.

The Acidaminococcaceae family encompasses several genera with Acidaminococcus as the type genus, alongside Phascolarctobacterium, Succiniclasticum, and Succinispira. These bacteria are characterized by their ability to utilize glutamate, trans-aconitate, citrate, and other non-carbohydrate substrates as energy sources, producing short-chain fatty acids including acetate, butyrate, and succinate. Their metabolic activities link protein fermentation to the production of beneficial metabolites, positioning them as important contributors to gut health.

Recent research from 2015 to 2025 has dramatically expanded our understanding of Acidaminococcaceae's clinical significance. Studies in pediatric malnutrition have identified Acidaminococcus species as potential biomarkers of growth faltering, with specific associations between their abundance and linear growth deficits in children from low-income countries. Concurrently, genomic investigations have revealed the presence of the aci1 beta-lactamase gene in Acidaminococcus intestini, highlighting this family as a reservoir of antibiotic resistance genes with global distribution. The family's unique metabolic capabilities and its role in protein fermentation make it a critical mediator of host-microbe interactions, particularly in the context of dietary protein intake and gut health.

---

Where It Is Found

Acidaminococcaceae bacteria are found predominantly in the gastrointestinal tracts of humans and other animals, with highest abundance in the colon.

Gastrointestinal Distribution

The family colonizes the large intestine, where protein fermentation substrates are most abundant. Unlike carbohydrate-fermenting bacteria that dominate the proximal colon, Acidaminococcaceae thrive in the distal colon where protein-derived substrates become more available. Their abundance is generally modest in healthy individuals, typically ranging from 1 to 5 percent of the gut microbiome, but they can become more prominent under specific dietary conditions.

Geographic and Population Distribution

Acidaminococcaceae show notable population-level variation, though less dramatic than the enterotype-defining differences seen with Prevotellaceae.

· Industrialized Populations: Individuals consuming Western diets high in animal protein show higher Acidaminococcaceae abundance compared to those consuming plant-rich diets. The increased availability of protein fermentation substrates supports their growth.

· Traditional Agrarian Populations: Individuals consuming plant-rich, high-fiber diets typical of rural Africa and South America show lower Acidaminococcaceae abundance, reflecting reduced protein fermentation substrates.

· Geographic Variation: Metagenomic surveys have identified Acidaminococcus species in human gut samples from Europe, China, and the United States, indicating global distribution.

Body Sites Beyond the Gut

· Oral Cavity: Some Acidaminococcaceae members are occasionally detected in the oral cavity, though they are not dominant members of oral microbial communities.

· Vaginal Tract: Certain species have been detected in the vaginal microbiome, though at lower abundance than Lactobacillus-dominated communities.

· Clinical Samples: Acidaminococcus intestini has been isolated from perianal abscesses and other clinical specimens, indicating its potential as an opportunistic pathogen in certain contexts.

Animal Reservoirs

Acidaminococcaceae members are abundant in the gastrointestinal tracts of various animals, particularly omnivores and carnivores. Acidaminococcus fermentans was originally isolated from pig intestines and has also been detected in cattle rumen, though it is not typically a predominant ruminal bacterium.

Factors Affecting Abundance

· Dietary Protein Intake: High consumption of animal protein increases the availability of amino acid substrates, promoting Acidaminococcaceae growth.

· Dietary Fiber Intake: High fiber intake may indirectly suppress Acidaminococcaceae by promoting carbohydrate-fermenting bacteria that outcompete them.

· Geographic Location: Populations consuming Westernized diets show higher abundance compared to those consuming traditional plant-rich diets.

· Antibiotic Exposure: As Gram-negative bacteria, Acidaminococcaceae are susceptible to antibiotics targeting Gram-negative cell walls, though some species carry beta-lactamase genes conferring resistance.

· Disease States: Abundance is altered in malnutrition, inflammatory conditions, and metabolic disorders.

External Sources

Acidaminococcaceae are not typically found in fermented foods or environmental sources. They are acquired through vertical transmission from mothers and horizontal transmission within families and communities during early life. Their establishment depends on dietary substrates that support their growth and persistence.

---

1. Taxonomic Insights

Family Name: Acidaminococcaceae Marchandin et al. 2010

Phylum: Bacillota (formerly Firmicutes)

Class: Negativicutes

Order: Acidaminococcales (or Selenomonadales, depending on taxonomic scheme)

Taxonomic Note

The family Acidaminococcaceae was established in 2010 as part of a major reclassification of the class Negativicutes, a group of bacteria that present a remarkable paradox within the phylum Bacillota. While Bacillota are typically Gram-positive with a single cell membrane (monoderms), Negativicutes possess a Gram-negative cell wall with an outer membrane (diderms), making them a unique evolutionary lineage. The family was formally described to accommodate the genera Acidaminococcus, Phascolarctobacterium, Succiniclasticum, and Succinispira, separating them from the related family Veillonellaceae based on phylogenetic and phenotypic characteristics .

Key Genera

· Acidaminococcus: The type genus and most extensively studied member, encompassing several species that ferment amino acids and tricarboxylic acids as energy sources. The name derives from its ability to use amino acids as a primary energy source.

· Phascolarctobacterium: A genus of non-spore-forming, Gram-negative cocci that produce succinate and acetate from carbohydrate fermentation. Some species are associated with beneficial metabolic outcomes.

· Succiniclasticum: A genus characterized by its ability to convert succinate to propionate, playing a role in cross-feeding networks.

· Succinispira: A genus of curved rods that produce succinate as a major fermentation end product.

Major Acidaminococcus Species and Their Habitats

Acidaminococcus fermentans (Acidaminococcaceae)

The type species of the genus, originally isolated from pig intestines. It is a Gram-negative, anaerobic coccus that ferments glutamate, citrate, and trans-aconitate as energy sources. It produces acetate, butyrate, CO2, and hydrogen as fermentation end products. This species is also found in human feces and has been used as a model organism for studying sodium-ion translocating decarboxylases .

Acidaminococcus intestini (Acidaminococcaceae)

A species isolated from human clinical samples, including perianal abscesses, and also found as a commensal in the human gut. It is notable for carrying the aci1 gene encoding a class A beta-lactamase, conferring resistance to penicillins and extended-spectrum cephalosporins. This species has been associated with polymicrobial infections and complex diseases such as rosacea .

Acidaminococcus sp. (unclassified species)

Unclassified Acidaminococcus species have been identified in metagenomic studies of the human gut microbiome. One such species has been associated with linear growth faltering in infants in Bangladesh and Malawi, suggesting a potential role in childhood malnutrition .

Major Phascolarctobacterium Species and Their Habitats

Phascolarctobacterium faecium (Acidaminococcaceae)

A Gram-negative, anaerobic coccus commonly found in human feces. It ferments carbohydrates to produce succinate and acetate and is often associated with beneficial metabolic outcomes, including improved insulin sensitivity and reduced inflammation.

Phascolarctobacterium succinatutens (Acidaminococcaceae)

A species that utilizes succinate as a growth substrate, converting it to acetate and propionate. It participates in cross-feeding networks within the gut microbial community.

Genomic Insights

The genomes of Acidaminococcaceae members are characterized by their moderate size, unique metabolic pathways, and the presence of mobile genetic elements carrying antibiotic resistance genes.

· Genome Size: Typically ranging from 2.0 to 3.5 Mbp, with A. fermentans possessing a genome of approximately 2.4 Mbp.

· GC Content: Moderate GC content ranging from 50 to 57 percent, which is higher than many other Bacillota.

· Unique Metabolic Pathways: Genomes encode enzymes for the fermentation of glutamate via the 2-hydroxyglutarate pathway and the decarboxylation of glutaconate via sodium-ion translocating decarboxylases. These pathways are rare among gut bacteria and define the family's metabolic specialization .

· Antibiotic Resistance Genes: The aci1 gene, encoding a class A beta-lactamase, is present in A. intestini and has been identified in metagenomic samples from Europe, China, and the USA, indicating global distribution. The gene is flanked by transposon sequences and can be mobilized by tailed prophages, facilitating horizontal gene transfer .

· Mobile Genetic Elements: Transposons and prophages play a role in the dissemination of the aci1 beta-lactamase gene within Negativicutes. The presence of these mobile elements suggests that Acidaminococcaceae can serve as reservoirs of antibiotic resistance genes for other gut bacteria .

Family Characteristics

Acidaminococcaceae share several defining features that distinguish them from other Bacillota.

· Gram-negative cell wall structure with an outer membrane containing lipopolysaccharides, atypical for the phylum Bacillota.

· Strictly anaerobic metabolism, with no growth on agar surfaces exposed to air.

· Cocci or curved rod morphology, often occurring in pairs or chains.

· Chemo-organotrophic, with amino acids and tricarboxylic acids serving as primary energy sources; carbohydrates are not fermented by most species.

· Production of acetate, butyrate, succinate, CO2, and hydrogen as fermentation end products.

· Oxidase and catalase negative.

· Complex nutritional requirements, often requiring specific amino acids and vitamins for growth .

---

2. Therapeutic Actions

Primary Actions

· Amino acid fermenter (protein degradation to SCFAs)

· Succinate producer (substrate for cross-feeding)

· Butyrate producer (indirect via cross-feeding networks)

· Glutamate and citrate metabolizer (tricarboxylic acid utilization)

· Acetate producer (energy substrate for colonocytes)

Secondary Actions

· Metabolic regulator (via SCFA production)

· Gut ecosystem engineer (cross-feeding networks)

· Antibiotic resistance reservoir (context-dependent, with clinical implications)

· Biomarker of protein fermentation (dietary protein intake)

---

3. Bioactive Components and Their Action

Short-Chain Fatty Acids (SCFAs)

The fermentation of amino acids and other substrates by Acidaminococcaceae produces SCFAs as primary metabolic end products, with acetate and butyrate being the most significant for host health.

· Acetate: Produced during the fermentation of glutamate, citrate, and other substrates. Acetate serves multiple functions including serving as an energy substrate for colonocytes, substrate for hepatic lipogenesis, and signaling molecule via G-protein coupled receptors. It enters the circulation and influences peripheral tissues, contributing to whole-body energy homeostasis.

· Butyrate: A key product of glutamate fermentation by Acidaminococcus species. Butyrate is the primary energy source for colonocytes, supports gut barrier integrity, and has anti-inflammatory properties via inhibition of histone deacetylases. The production of butyrate from amino acids rather than carbohydrates is a distinctive feature of Acidaminococcaceae metabolism .

· Succinate: A major fermentation end product for many Acidaminococcaceae members, particularly Phascolarctobacterium species. Succinate can be absorbed by the host or converted to propionate by other community members, contributing to the metabolic network that sustains diverse microbial populations.

Unique Metabolic Pathways

The metabolic pathways of Acidaminococcaceae are highly specialized and distinct from those of typical carbohydrate-fermenting gut bacteria.

· Glutamate Fermentation: Acidaminococcus species ferment glutamate via the 2-hydroxyglutarate pathway, producing acetate, butyrate, CO2, and hydrogen. This pathway involves the enzyme 2-hydroxyglutaryl-CoA dehydratase and a sodium-ion translocating glutaconyl-CoA decarboxylase, which generates a sodium ion gradient used for ATP synthesis. This sodium-ion gradient is a unique energy-conservation mechanism among gut bacteria .

· Citrate and trans-Aconitate Fermentation: A. fermentans can ferment citrate and trans-aconitate to acetate, CO2, and hydrogen. This ability is rare among gut bacteria and allows Acidaminococcaceae to utilize tricarboxylic acids that are not accessible to most other microbes .

· Succinate Metabolism: Succiniclasticum and Succinispira species convert succinate to propionate, while Phascolarctobacterium species can utilize succinate as a growth substrate. These activities position Acidaminococcaceae as key players in cross-feeding networks, linking the metabolism of other bacteria to the production of beneficial SCFAs.

Cross-Feeding Metabolites

Beyond directly produced SCFAs, Acidaminococcaceae generate metabolic intermediates that feed other members of the gut microbial community.

· Succinate: Serves as substrate for propionate production by other community members, including Phascolarctobacterium and Succiniclasticum species. This metabolic network enhances overall propionate production beyond what individual species could achieve.

· Acetate: In addition to direct host effects, acetate is utilized by butyrogenic bacteria including Faecalibacterium prausnitzii and Roseburia species, supporting the production of butyrate, the primary energy source for colonocytes.

· Hydrogen: Produced during amino acid fermentation, hydrogen can be utilized by hydrogenotrophic methanogens and sulfate-reducing bacteria, contributing to the metabolic network that maintains gut ecosystem stability.

Antibiotic Resistance Mechanisms

The presence of beta-lactamase genes in Acidaminococcaceae has significant clinical implications.

· ACI-1 Beta-Lactamase: The aci1 gene encodes a class A beta-lactamase that confers resistance to penicillins and extended-spectrum cephalosporins. This enzyme is phylogenetically distinct from beta-lactamases of Gram-positive Bacillota and represents a unique resistance mechanism within the gut microbiome .

· Mobile Genetic Elements: The aci1 gene is flanked by transposon sequences and can be mobilized by tailed prophages. This mobile element context facilitates horizontal gene transfer, potentially spreading resistance genes to other gut bacteria and opportunistic pathogens .

· Global Distribution: Metagenomic surveys have identified the aci1 gene in human gut samples from Europe, China, and the USA, with a prevalence of approximately 4.4 percent of samples. This global distribution highlights the importance of Acidaminococcaceae as a reservoir of antibiotic resistance genes .

---

4. Clinical and Therapeutic Applications

Childhood Malnutrition and Growth Faltering

The association between Acidaminococcus species and linear growth in children represents one of the most significant clinical findings for this family.

· Growth Faltering Associations: A study of twin cohorts in Bangladesh and Malawi identified that the abundance of an unclassified Acidaminococcus species was associated with future linear growth deficits in infants. Children with higher Acidaminococcus abundance showed reduced length-for-age z-scores, suggesting a potential role in the pathogenesis of stunting .

· Mechanistic Considerations: The mechanisms linking Acidaminococcus to growth faltering are not fully understood but may involve competition for amino acids essential for host growth, production of metabolites that affect host metabolism, or disruption of the gut microbial community structure. The association with growth faltering highlights the complex interplay between gut microbiota composition and childhood nutrition.

· Clinical Implications: Acidaminococcus abundance may serve as a biomarker for identifying children at risk of growth faltering, enabling early intervention. Further research is needed to determine whether this association is causal and to identify potential therapeutic strategies targeting this bacterial family .

Antibiotic Resistance and Clinical Infections

The presence of beta-lactamase genes in Acidaminococcaceae has important implications for antibiotic therapy and infection control.

· Reservoir of Resistance Genes: A. intestini and related species carry the aci1 beta-lactamase gene, which can be transferred to other bacteria via mobile genetic elements. This positions Acidaminococcaceae as a potential source of antibiotic resistance for opportunistic pathogens .

· Clinical Isolates: A. intestini has been isolated from perianal abscesses and other clinical samples, indicating its potential as an opportunistic pathogen in immunocompromised individuals or in polymicrobial infections. The presence of beta-lactamase genes complicates antibiotic treatment and may contribute to treatment failures .

· Global Distribution: The detection of aci1 in human gut samples across three continents indicates that Acidaminococcaceae are a globally distributed reservoir of antibiotic resistance. This highlights the need for surveillance of resistance genes in commensal bacteria and for antibiotic stewardship to limit the spread of resistance .

Metabolic Health and SCFA Production

Through its production of SCFAs, Acidaminococcaceae may influence metabolic health.

· Butyrate Production: The production of butyrate from amino acids provides an alternative source of this beneficial SCFA in individuals consuming low-fiber, high-protein diets. Butyrate supports gut barrier integrity, reduces inflammation, and improves insulin sensitivity, potentially offsetting some of the negative effects of low-fiber diets .

· Succinate Metabolism: Phascolarctobacterium species utilize succinate, converting it to acetate and propionate. This activity reduces succinate accumulation, which has been associated with inflammatory conditions, while producing beneficial SCFAs.

· Cross-Feeding Networks: By producing succinate and acetate, Acidaminococcaceae support the growth of butyrogenic bacteria, contributing to overall SCFA production and gut health. This cross-feeding role positions them as keystone organisms in the gut microbial community.

Inflammatory Bowel Disease (IBD)

The role of Acidaminococcaceae in IBD is complex and requires further investigation.

· Abundance Changes: Some studies report altered Acidaminococcaceae abundance in IBD patients compared to healthy controls, though findings are inconsistent. The variability may reflect differences in disease subtype, activity, diet, and individual patient factors.

· Mechanistic Considerations: The SCFAs produced by Acidaminococcaceae, particularly butyrate, have anti-inflammatory properties that could protect against IBD. However, the production of hydrogen and other metabolites may have context-dependent effects that could exacerbate inflammation in susceptible individuals.

Polymicrobial Infections

Acidaminococcaceae have been detected in polymicrobial infections, including abscesses and wound infections.

· Co-infection: A. intestini and other Acidaminococcaceae are often found in polymicrobial infections alongside other anaerobic bacteria. Their presence may complicate treatment and contribute to disease severity.

· Rosacea Association: A. intestini has been associated with rosacea, a chronic inflammatory dermatosis. The mechanisms linking gut bacteria to skin conditions remain unclear but may involve immune modulation or metabolite production.

---

5. Therapeutic Preparations and Formulations

Live Biotherapeutic Products

Purpose: Not currently available. Acidaminococcaceae are not typically used as probiotics due to their complex growth requirements and potential antibiotic resistance gene carriage. Future therapeutic applications may focus on targeted modulation rather than direct supplementation.

Consortia Formulations

Purpose: To replicate the functional capacity of complex microbial communities, including protein fermentation networks.

· Multi-Species Consortia: Combining Acidaminococcaceae with carbohydrate-fermenting bacteria could create balanced communities capable of utilizing both dietary fiber and protein. Such consortia could be designed for individuals with specific dietary patterns or metabolic needs.

· Cross-Feeding Partners: Including butyrate-producing bacteria alongside Acidaminococcaceae could enhance overall SCFA production, as Acidaminococcaceae-produced succinate and acetate serve as substrates for butyrogenesis.

Dietary Interventions to Modulate Endogenous Acidaminococcaceae

Purpose: To manage abundance and activity through dietary modification.

· Protein Intake Management: High protein intake, particularly from animal sources, increases Acidaminococcaceae abundance. For individuals with overgrowth or growth faltering associations, reducing protein intake may help restore balance.

· Fiber Intake Enhancement: Increasing dietary fiber promotes carbohydrate-fermenting bacteria that may outcompete Acidaminococcaceae, potentially reducing their abundance and associated risks.

· Balanced Diet: Consuming a balanced diet with appropriate proportions of protein, carbohydrates, and fiber supports a diverse gut microbiome and may prevent overgrowth of any single bacterial group.

Prebiotic Strategies

Purpose: To indirectly modulate Acidaminococcaceae through substrate manipulation.

· Amino Acid Availability: Limiting availability of specific amino acids, particularly glutamate, may reduce Acidaminococcaceae growth. This could be achieved through dietary modifications or by promoting competing bacteria that utilize these substrates.

· Succinate Modulation: Phascolarctobacterium species utilize succinate. Modulating succinate availability through dietary or microbial interventions could influence their abundance.

Antibiotic Stewardship

Purpose: To limit the spread of antibiotic resistance genes carried by Acidaminococcaceae.

· Judicious Antibiotic Use: Avoiding unnecessary antibiotic prescriptions, particularly beta-lactams, reduces selection pressure for resistance genes carried by Acidaminococcaceae.

· Resistance Surveillance: Monitoring for the presence of aci1 and other resistance genes in clinical samples can inform antibiotic selection and infection control practices.

---

6. In-Depth Mechanistic Profile and Clinical Significance

The Gram-Negative Firmicutes: A Unique Evolutionary Lineage

Acidaminococcaceae belong to the class Negativicutes, a group of bacteria that present a remarkable evolutionary paradox. While all other members of the phylum Bacillota (formerly Firmicutes) possess a Gram-positive cell wall with a single membrane, Negativicutes have a Gram-negative cell wall with an outer membrane containing lipopolysaccharides. This unique cell wall structure has profound implications for their biology, including their susceptibility to antibiotics, their interaction with the host immune system, and their evolutionary history .

· Cell Wall Composition: The cell wall contains meso-diaminopimelic acid and the whole cells contain galactose, glucose, and ribose. Menaquinones and ubiquinones are absent, further distinguishing them from typical Gram-negative bacteria .

· Evolutionary Implications: The presence of a Gram-negative cell wall in a phylum of Gram-positive bacteria suggests that the outer membrane was either acquired through horizontal gene transfer from Proteobacteria or was present in an ancestral lineage and lost in most other Bacillota. This evolutionary uniqueness makes Negativicutes a valuable model for studying cell wall evolution and host-microbe interactions .

Protein Fermentation and SCFA Production

The metabolic specialization of Acidaminococcaceae on amino acids and tricarboxylic acids has important implications for gut health.

· Alternative Butyrate Pathway: In individuals consuming low-fiber, high-protein diets, butyrate production from carbohydrates is reduced. Acidaminococcaceae provide an alternative source of butyrate through glutamate fermentation, helping to maintain gut barrier function and anti-inflammatory signaling even in the absence of adequate dietary fiber .

· Sodium Ion Gradient Energy Conservation: The fermentation of glutamate involves a sodium-ion translocating glutaconyl-CoA decarboxylase, which generates a sodium ion gradient used for ATP synthesis. This mechanism is unique among gut bacteria and allows Acidaminococcaceae to thrive in environments where other energy-conservation mechanisms are less efficient .

· Hydrogen Production: The production of hydrogen during amino acid fermentation supports hydrogenotrophic methanogens and sulfate-reducing bacteria, contributing to the metabolic network that maintains gut ecosystem stability.

Cross-Feeding Networks and Community Structure

Acidaminococcaceae function as keystone organisms in gut microbial communities, shaping ecosystem structure through metabolic interactions.

· Succinate Utilization: Phascolarctobacterium and Succiniclasticum species convert succinate to propionate and acetate, linking the metabolism of other bacteria to the production of beneficial SCFAs. This activity reduces succinate accumulation, which can be pro-inflammatory in high concentrations .

· Acetate Provision: Acetate produced by Acidaminococcaceae serves as substrate for butyrogenic bacteria including Faecalibacterium prausnitzii and Roseburia species, which convert it to butyrate. This cross-feeding relationship links protein fermentation to the production of the primary energy source for colonocytes.

· Amino Acid Competition: By utilizing amino acids as energy sources, Acidaminococcaceae compete with the host for these essential nutrients. In contexts of malnutrition or growth faltering, this competition could contribute to nutrient deficiencies and impaired growth .

Antibiotic Resistance: A Global Health Concern

The presence of the aci1 beta-lactamase gene in Acidaminococcaceae highlights the importance of commensal bacteria as reservoirs of antibiotic resistance.

· Gene Structure and Function: The ACI-1 beta-lactamase is a class A enzyme that hydrolyzes penicillins and extended-spectrum cephalosporins. It is phylogenetically distinct from other class A beta-lactamases of Gram-positive Bacillota, suggesting a unique evolutionary origin .

· Mobile Element Context: The aci1 gene is flanked by transposon sequences and can be mobilized by tailed prophages. This mobile element context facilitates horizontal gene transfer, potentially spreading resistance genes to other gut bacteria and opportunistic pathogens .

· Global Prevalence: Metagenomic surveys have identified aci1 in 4.4 percent of human gut samples from Europe, China, and the USA. This global distribution suggests that Acidaminococcaceae are a significant reservoir of resistance genes with potential clinical impact .

An Integrated View of Healing with Acidaminococcaceae

· For Childhood Malnutrition and Growth Faltering: The association between Acidaminococcus abundance and linear growth deficits suggests that modulating this bacterial family could be a therapeutic target for preventing stunting. Dietary interventions that reduce protein fermentation or promote competing bacteria may help restore normal growth patterns in at-risk children. Further research is needed to determine whether the association is causal and to identify optimal intervention strategies .

· For Antibiotic Resistance Management: The carriage of beta-lactamase genes by Acidaminococcaceae highlights the importance of surveillance for resistance genes in commensal bacteria. Antibiotic stewardship, including judicious use of beta-lactams, can reduce selection pressure for resistance and limit the spread of aci1 and related genes .

· For Metabolic Health: The production of butyrate from amino acids provides an alternative pathway for this beneficial SCFA in individuals consuming low-fiber diets. Supporting Acidaminococcaceae through balanced protein intake may help maintain gut barrier function and anti-inflammatory signaling even when fiber intake is inadequate .

· As a Biomarker of Dietary Patterns: Acidaminococcaceae abundance serves as a biomarker of dietary protein intake and protein fermentation activity. Monitoring their abundance could inform dietary recommendations and help identify individuals at risk for conditions associated with high protein fermentation.

---

7. Dietary Strategies to Modulate Endogenous Acidaminococcaceae

Purpose: To manage the abundance and activity of Acidaminococcaceae in the gut microbiome.

Balance Protein Intake

Dietary protein intake is the primary determinant of Acidaminococcaceae abundance.

· Moderate Protein Consumption: Consuming protein in moderation, within recommended dietary allowances, supports a balanced gut microbiome without promoting overgrowth of protein-fermenting bacteria. Excessive protein intake, particularly from animal sources, increases substrate availability for Acidaminococcaceae.

· Protein Source Considerations: Plant-based proteins may have different fermentation profiles compared to animal-based proteins. Individuals with concerns about Acidaminococcaceae overgrowth may benefit from reducing animal protein intake.

Increase Dietary Fiber

Dietary fiber promotes carbohydrate-fermenting bacteria that can outcompete Acidaminococcaceae.

· Diverse Fiber Sources: Consuming a variety of plant foods provides diverse fiber substrates that support a broad range of carbohydrate-fermenting bacteria. This diversity can help maintain a balanced gut microbial community and prevent overgrowth of any single bacterial group.

· Target Fiber Intake: Intakes of 25 to 35 grams of dietary fiber daily support carbohydrate-fermenting bacteria and may reduce Acidaminococcaceae abundance.

Incorporate Fermented Foods

Fermented foods may influence gut microbial composition through multiple mechanisms.

· Probiotic Bacteria: Fermented foods introduce beneficial bacteria that can compete with Acidaminococcaceae for resources and ecological niches.

· Metabolites: Fermented foods contain SCFAs and other metabolites that may influence gut microbial composition and host physiology.

Avoid Excessive Processed Meat Consumption

Processed meats are particularly rich in amino acids and may promote protein-fermenting bacteria.

· Limit Intake: Reducing consumption of processed meats, including bacon, sausage, and deli meats, reduces substrate availability for Acidaminococcaceae.

· Focus on Whole Foods: Consuming whole food sources of protein, such as legumes, nuts, and unprocessed meats, supports a balanced gut microbiome.

---

8. Foods and Factors to Limit

Excessive Animal Protein

High intake of animal protein, particularly red and processed meats, is the primary factor associated with increased Acidaminococcaceae abundance.

· Amino Acid Substrates: Animal proteins provide abundant amino acids that serve as energy sources for Acidaminococcaceae. The fermentation of these amino acids produces SCFAs but also generates hydrogen and other metabolites that can affect gut health.

· Potential Risks: In susceptible individuals, high protein intake may promote overgrowth of Acidaminococcaceae, potentially contributing to growth faltering in children or exacerbating inflammatory conditions.

Low-Fiber Diets

Diets low in dietary fiber fail to support carbohydrate-fermenting bacteria that compete with Acidaminococcaceae.

· Competitive Exclusion: Carbohydrate-fermenting bacteria outcompete protein-fermenting bacteria when fiber is abundant. Low-fiber diets remove this competitive pressure, allowing Acidaminococcaceae to proliferate.

· Western Dietary Patterns: The typical Western diet high in animal protein and low in fiber promotes Acidaminococcaceae growth and may contribute to the health consequences associated with this dietary pattern.

Antibiotic Overuse

Broad-spectrum antibiotics, particularly those with activity against Gram-negative bacteria, can deplete Acidaminococcaceae populations.

· Susceptibility: As Gram-negative bacteria, Acidaminococcaceae are susceptible to many common antibiotics, though some species carry beta-lactamase genes conferring resistance.

· Resistance Selection: Antibiotic use selects for resistant strains, potentially increasing the prevalence of aci1 and other resistance genes in the gut microbiome.

---

9. Therapeutic Potential in Specific Disease States: A Summary

Childhood Malnutrition and Growth Faltering

Higher Acidaminococcus abundance is associated with future linear growth deficits in infants in low-income countries. This association suggests that modulating this bacterial family could be a therapeutic target for preventing stunting. Dietary interventions that reduce protein fermentation or promote competing bacteria may help restore normal growth patterns. Further research is needed to determine causality and identify optimal intervention strategies .

Antibiotic Resistance

Acidaminococcaceae carry the aci1 beta-lactamase gene, which confers resistance to penicillins and cephalosporins. This gene is globally distributed and can be mobilized by transposons and prophages. Surveillance for resistance genes in commensal bacteria and antibiotic stewardship are critical for limiting the spread of resistance .

Metabolic Health

Through the production of butyrate, acetate, and succinate, Acidaminococcaceae contribute to SCFA production and gut barrier function. Their ability to produce butyrate from amino acids provides an alternative source of this beneficial SCFA in individuals consuming low-fiber diets. Supporting these bacteria through balanced protein intake may help maintain metabolic health .

Inflammatory Bowel Disease

The role of Acidaminococcaceae in IBD is complex and requires further investigation. SCFA production may have protective effects, while other metabolites may contribute to inflammation in susceptible individuals. Personalized approaches based on individual patient factors may be necessary.

Polymicrobial Infections

Acidaminococcaceae have been isolated from perianal abscesses and other clinical samples, indicating their potential as opportunistic pathogens. The presence of beta-lactamase genes complicates antibiotic treatment and may contribute to treatment failures.

---

10. Conclusion

The family Acidaminococcaceae stands as a testament to the remarkable diversity and specialization of the human gut microbiome. As master fermenters of amino acids, these bacteria occupy a distinct metabolic niche that links protein intake to the production of beneficial short-chain fatty acids. Their unique Gram-negative cell wall structure within a phylum of typically Gram-positive bacteria highlights the evolutionary complexity of the microbial world and the importance of understanding microbial taxonomy for interpreting host-microbe interactions.

The scientific advances of the past decade have deepened our appreciation for both the potential benefits and the clinical significance of Acidaminococcaceae. The discovery of the aci1 beta-lactamase gene in A. intestini and its global distribution highlights the importance of commensal bacteria as reservoirs of antibiotic resistance, with implications for antibiotic stewardship and infection control. The association between Acidaminococcus abundance and childhood growth faltering opens new avenues for understanding the role of the gut microbiome in malnutrition and for developing interventions to prevent stunting.

Yet the complexity of Acidaminococcaceae's role in health and disease demands a nuanced approach. Their protein-fermenting metabolism provides an alternative source of butyrate in low-fiber diets, potentially offering benefits for gut barrier function and inflammation. However, in contexts of excessive protein intake or malnutrition, their activity may contribute to growth deficits or other adverse outcomes. The future of Acidaminococcaceae-based therapeutics lies in understanding these context-dependent effects and developing personalized approaches that harness their benefits while minimizing risks.

As research continues to unravel the intricacies of this fascinating bacterial family, Acidaminococcaceae are poised to become important players in microbiome-directed strategies for addressing childhood malnutrition, managing antibiotic resistance, and optimizing metabolic health across the lifespan.

---

11. Reference Books for In-Depth Study

· Bergey's Manual of Systematics of Archaea and Bacteria by William B. Whitman (Editor-in-Chief)

· The Human Microbiota and Chronic Disease: Dysbiosis as a Cause of Human Pathology by Luigi Nibali and Brian Henderson

· Gut Microbiota: Interactive Effects on Nutrition and Health by Edward Ishiguro, Natasha Haskey, and Kristina Campbell

· The Gut Microbiome: Bench to Table by Jennifer M. Auchtung and Robert A. Britton

· Metabolic Interactions Between Bacteria and the Host by Ursula Keller and Wolf-Dieter Hardt

· Current research literature in journals including Microbiome, The ISME Journal, Gut, Nature Microbiology, Applied and Environmental Microbiology, and International Journal of Systematic and Evolutionary Microbiology.

---

12. Further Study: Microbes and Interventions That Might Interest You Due to Similar Therapeutic Properties

Veillonella Species (Veillonellaceae)

Phylum: Bacillota (Negativicutes)

Similarities: Like Acidaminococcaceae, Veillonella are Gram-negative cocci within the class Negativicutes. They ferment lactate to acetate and propionate, playing a key role in cross-feeding networks. Veillonella are abundant in the oral cavity and gut, and their study provides insights into the broader biology of Negativicutes.

Megasphaera elsdenii (Veillonellaceae)

Phylum: Bacillota (Negativicutes)

Similarities: Megasphaera is another Negativicute that ferments lactate and produces butyrate. It is used as a probiotic in ruminants to prevent lactic acidosis and is being investigated for similar applications in humans. Its metabolic capabilities overlap with those of Acidaminococcaceae, particularly in SCFA production.

Clostridium butyricum (Clostridiaceae)

Phylum: Bacillota

Similarities: Like Acidaminococcaceae, C. butyricum produces butyrate, though from carbohydrate fermentation rather than amino acids. It is used as a probiotic in some countries and has been studied for its anti-inflammatory effects. The complementary butyrate production pathways of these two groups illustrate the functional redundancy of the gut microbiome.

Succinate Producers and Utilizers

Intervention: Microbial communities

Similarities: Understanding how Acidaminococcaceae produce and utilize succinate illuminates the broader principles of cross-feeding networks in the gut microbiome. Succinate serves as a key intermediate linking different microbial groups, and its accumulation or depletion has important implications for gut health.

Protein Fermentation and Host Metabolism

Intervention: Dietary strategies

Similarities: The study of protein fermentation by Acidaminococcaceae provides insights into the metabolic consequences of high-protein diets and the role of the gut microbiome in protein metabolism. Understanding these pathways can inform dietary recommendations for individuals with specific metabolic needs.

---

Disclaimer

The family Acidaminococcaceae encompasses diverse bacterial species with complex, context-dependent effects on human health. While some members produce beneficial short-chain fatty acids, others carry antibiotic resistance genes with clinical implications. The association between Acidaminococcus abundance and childhood growth faltering requires further research to establish causality and identify intervention strategies. Live biotherapeutic products based on Acidaminococcaceae are not currently available, and dietary strategies to modulate these bacteria should be implemented as part of overall healthy eating patterns. This information is for educational purposes only and is not a substitute for professional medical advice.